Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 January 2022 | Story Rulanzen Martin | Photo Charl Devenish
The Free State once again excelled in the NSC matric results. Pictured here is a broadcast of a celebratory event held by the FSDoE on the UFS South Campus in 2021 for the matric class of 2020.

The Free State has claimed the top spot in the National Senior Certificate (NSC) examination results for the third consecutive year, with a pass rate of 85,7% in 2021. 

“On behalf of the executive management, staff, and students of the University of the Free State (UFS), I would like to extend our warmest congratulations to you and your executive team on the Free State being the top-achieving province,” Prof Francis Petersen, UFS Rector and Vice-Chancellor, wrote in a congratulatory letter to Dr Tate Makgoe, MEC for Education in the Free State. 

“The UFS is proud to be associated with the Free State Department of Education and we salute you and your team for the many initiatives in schools across the province, which have contributed to the outstanding matric results this year,” Prof Petersen said. 

The UFS will welcome several first-year students on its three campuses in February – many of whom hail from schools in the Free State. The 2021 NSC results were released on 20 January 2022. 
 
Several UFS-led interventions thrive to make impactful change 

The UFS is leading several projects with the Department of Education to address education-related problems in the province. The UFS, through its South Campus, presents the In-Service (InSET) programme, the Internet Broadcast Project (IBP), and the Schools Partnership Project. “It is projects such as these that make a huge difference in the lives of many learners and teachers in our province and that have given so many schools the opportunity to rise to the occasion,” Prof Petersen said. 

The IBP supports learners from 80 schools, with lessons for learners in Grades 8 to 12 being transmitted to three centres across the Free State on a daily basis. Electronic access to learning material is also made possible through the IBP. The Schools Partnership Project, as part of the Social Responsibility Project at the UFS, is focused on the efficacy and quality of school management, subject teaching, and learning development. Well-trained mentors visit project schools on a daily basis, sharing knowledge, materials, and demonstrating the use of technology in an effort to improve the standard of teaching. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept